Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734404 · ClinicalTrials.gov registry record
Longitudinal Study for Central Nervous System Vasculitis
A clinical trial of Vasculitis and CNS Vasculitis, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 40
- Enrollment target
- 6
- Study locations
NCT05734404: Recruiting study of Vasculitis and CNS Vasculitis, sponsored by University of Pennsylvania.
NCT05734404 is a study of Vasculitis and CNS Vasculitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 40 participants, below the 27,315-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05734404, a study of Vasculitis and CNS Vasculitis, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 6
- Study locations
Study Summary
Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.
Primary Outcome
To study the manner of development of disease in patients affected with central nervous system vasculitis.
Conditions Studied
Study Locations (6)
Other
- St. Joseph's Healthcare - Hamilton
- University of Toronto/Sinai Health - Toronto
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- University of Pennsylvania - Philadelphia
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2030-12-31 |
What NCT05734404 shows while recruiting
NCT05734404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 27,315-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.
NCT05734404 lists 6 locations in 5 states (Other, Minnesota, Ohio).
Frequently Asked Questions
What is clinical trial NCT05734404 about?
NCT05734404 is a clinical study titled "Longitudinal Study for Central Nervous System Vasculitis". Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a rese...
What is the current status of trial NCT05734404?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-03-01. Estimated completion is 2030-12-31.
What conditions does trial NCT05734404 study?
This clinical trial studies the following conditions: Vasculitis, CNS Vasculitis, Central Nervous System Vasculitis, CNSV.
Who is sponsoring clinical trial NCT05734404?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05734404 being conducted?
This trial has 6 study locations across Minnesota, Ohio, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05734404's enrollment target sits among peer trials
40 7th of 11 higher than 5 of 11 other Vasculitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vasculitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Study for Relapsing Polychondritis
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI